Study on weight loss surgery for heart failure with irregular heartbeat
Part of Heart & circulation clinical trials.
This trial tests if weight loss surgery can help people with heart failure and atrial fibrillation (an irregular heartbeat) improve their heart condition. You may join if you are between 45 and 70, have a BMI of 32 to 40, and have mild to moderate heart failure with preserved pumping function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms of heart failure as defined by heart doctors
- Your heart's pumping strength is at least 40%
- You have an irregular heartbeat (atrial fibrillation) that comes and goes or is persistent
- You are between 45 and 70 years old
- Your body mass index (BMI) is 32 to 40
- You are willing to consider both treatment approaches: surgery and medical care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether weight-loss surgery can help control or eliminate atrial fibrillation (an irregular heartbeat) in people with obesity. If you qualify, you would receive either gastric bypass or sleeve gastrectomy and be monitored for changes in your heart rhythm.
This study tests whether a procedure called catheter ablation, which treats irregular heartbeats in atrial fibrillation, can improve outcomes in people who also have heart failure with mildly reduced or preserved pumping function. The procedure aims to restore a normal heart rhythm and may help reduce symptoms.
This trial looks at whether a special heart rhythm treatment called “ablation” works well when done during certain heart operations. It may help reduce atrial fibrillation (AF) symptoms or future abnormal rhythm episodes for people who are already having surgery.
This trial tests whether early catheter ablation (a procedure to fix irregular heartbeats) helps people who have both heart failure and atrial fibrillation. It looks at how this treatment affects your heart function and quality of life.
This trial tests whether a catheter procedure that treats atrial fibrillation works better than standard care for people with heart failure with preserved ejection fraction. It aims to improve heart rhythm symptoms and overall outcomes compared with conventional treatment.
This study looks at patients who have both atrial fibrillation (irregular heartbeats) and heart failure. It aims to predict health outcomes for people who are having a procedure called ablation, which aims to restore a normal heart rhythm. Participating could help doctors understand who might benefit most from this treatment.
Hear when a new Heart Failure With Preserved Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.